The reduction of GLUT-1 expression as a consequence of CF administration was up to 70% in U937 cells. Figure 6 Western Blotting CX-5461 cell line analysis of GLUT-1 receptor in Jurkat, U937, and K562 leukemia cell lines after 72 h of incubation with CF (5 μl/ml) as compared to untreated cells (control). Results are representative of three independent experiments. Other than GLUT-1 up-regulation, the activation of HIF-1 also contributes to the conversion of glucose to lactate. In
fact, when stabilized, HIF-1α is directly LGX818 chemical structure involved in the overexpression of many glycolytic enzymes as well as LDH, the NADH-dependent enzyme that catalyzes the conversion of pyruvate to lactate . Based on the observed strong LDH dependency for tumor proliferation
from both in vitro and in vivo studies [39, 40], inhibition of LDH may represent an alternative strategy toward the development of anti-glycolytic-based therapeutic strategies for the treatment of cancer. Noteworthy, our data revealed that CF induced a significant decrease in LDH activity after 72 hours from its administration (up to 28%) (Figure 7A). At the same time, the amount of lactate released in the extracellular environment was also reduced in CF treated cells as compared to untreated cells (up see more to 37%) (Figure 7B). Figure 7 LDH activity (A) and lactate release in the culture medium (B) in leukemia cells after 72 h of incubation with CF (5 μl/ml) in comparison with untreated cells (control). Data are expressed as mean ± SD of at least three independent experiments. *p < 0.05 vs.
untreated cells. The reversion of the glycolytic phenotype is known to render tumor cells susceptible to apoptosis and decrease their growth rate [15–17]. In this context, our findings are in accord with recent observations indicating that the in vitro inhibition of tumor cell survival (T cell lymphoma) by compounds targeting tumor metabolism was accompanied Cyclin-dependent kinase 3 by a modulation of lactate concentration in the tumor-conditioned medium, by altered expression of HIF-1α and by an alteration in the expression of apoptotic (such as caspase-3) and cell survival regulatory molecules (such as GLUT-1) . Another important control point might be the glycolytic enzyme glyceraldehyde 3-phosphate dehydrogenase (GAPDH) . If the oxygen supply is normal, NADH reducing equivalents that are generated by GAPDH are transported inside the mitochondria in order to reach the respiratory chain. In hypoxic conditions, the above reducing equivalents are used by LDH to convert pyruvate into lactate and no ATP can be produced into the mitochondria. This reaction is prominent in tumor cells, thus the evaluation of CF effect on GAPDH activity could also be of great interest.